Jesper Jensen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Venues

Basic & clinical pharmacology & toxicology

Diabetes, obesity & metabolism

Cardiovascular diabetology

Circulation. Heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Jesper Jensen, Massar Omar, Caroline Kistorp, Finn Gustafsson, Lars Køber, Jacob Eifer Møller, Morten Schou
Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives. Basic & clinical pharmacology & toxicology 131 (1) (2022)
Jesper Jensen, Massar Omar, Caroline Kistorp, Christian Tuxen, Mikael Kjær Poulsen, Jens Faber, Lars Valeur Køber, Finn Gustafsson, Jacob Eifer Møller, Morten Schou
Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial. Circulation. Heart failure 15 (8) (2022)
Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W Hansen, Magnus T Jensen, Henrik U Andersen, Peter Rossing, Tina Vilsbøll, Peter G Jørgensen
MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction. Cardiovascular diabetology 19 (1) (2020)
Jesper Jensen, Massar Omar, Caroline Kistorp, Mikael Kjær Poulsen, Christian Tuxen, Ida Gustafsson, Lars Køber, Finn Gustafsson, Emil Fosbøl, Niels Eske Bruun, Lars Videbæk, Peter Hartmund Frederiksen, Jacob Eifer Møller, Morten Schou
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF). Trials 20 (1) (2019)
Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W Hansen, Magnus T Jensen, Henrik U Andersen, Peter Rossing, Tina Vilsbøll, Peter G Jørgensen
Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes. Diabetes, obesity & metabolism 21 (3) (2018)

Jesper Jensen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jesper Jensen